Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung
A legfontosabb adatok
- Ki végzi
- Ohio State University Comprehensive Cancer Center
- Hol
- Columbus (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Visszavonva
- Kezdés
- 2024. jan. 1.
- Befejezés
- 2024. jan. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Best Practice
- Nicotine Replacement
- Quality-of-Life Assessment
- Questionnaire Administration
- A regiszteradat frissítve
- 2024. április 12.
- Miért állt le
- Funding lapse
Ki vehet részt
- Életkor
- 21 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Newly diagnosed lung cancer subjects will be stages I-III non-small cell lung cancer (NSCLC) and head and neck cancer subjects will be stages I-IV squamous cell carcinoma (SCC)
- Current smokers of combustible cigarettes who smoke >= 4 days/week
- Lung cancer patients planning to undergo wedge resection surgery for their index cancer
- Head and neck cancer patients planning to undergo surgical resection of their index cancer or exploratory biopsies (tonsil cancer)
- Patients must intend to receive ongoing oncology care at Ohio State University [OSU] (i.e., their clinic visit is not a consultation/second opinion)
- Patients that are over the age of 21 years
Ki nem vehet részt
- Patients who are planning to use or are currently using cessation medication to help quit or reduce smoking
- Patients who are currently using e-cigarettes
- Patients undergoing surgery including lobectomy, pneumonectomy, tracheotomy, laryngectomy, or free flap surgery
- Lung cancer patients who are on home supplemental oxygen at baseline
- Patients with nasopharyngeal, thyroid, or gland cancers
- Patients under 21 years of age
- Patients who are cognitively unable to understand the consent form or participate in interviews
- Patients with hearing impairments
- Patients with contraindications to per oral intake
- Patients that have problems with dexterity that would impact electronic cigarette use
- Patients who don't speak and read English
- Patients with histologies other than NSCLC, or squamous cell carcinoma of the head and neck
- Patients with inoperable tumors
- Pregnant women
- Prisoners
Helyszínek itt: Egyesült Államok
- Ohio State University Comprehensive Cancer CenterColumbus, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This clinical trial investigates the acceptability of electronic cigarettes (JUUL) for smoking cessation (quitting smoking) and the reduction of surgery-related complications in patients with newly diagnosed head, neck, or lung cancer. Smoking before surgery is associated with increased risk of complications during and after surgery. Electronic cigarettes are a type of special product that gives small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking. Stopping cigarette smoking before surgery may reduce the risk of complications during and after surgery in patients with head, neck, or lung cancer.
A vizsgálat 2 csoportja
- Arm I (JUUL)A vizsgált kezelés
Beginning 1 month before surgery, patients receive a JUUL e-cigarette and a 1 month supply e-liquid pods. After completion of surgery, patients receive another 1 month supply of e-liquid pods.
Kezelés: Nicotine Replacement, Quality-of-Life Assessment és Questionnaire Administration
- Arm II (usual care)Már használt kezelés, összehasonlításként
Patients receive usual care.
Kezelés: Best Practice, Quality-of-Life Assessment és Questionnaire Administration
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Pilot Trial of Electronic Cigarettes in Patients Diagnosed With Cancers of the Head, Neck, and Lung
- A regiszteradat frissítve
- 2024. április 12.